We are live on ! Find out more
FG

Fairman Group Portfolio holdings

AUM $117M
1-Year Est. Return 5.24%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+5.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$124M
AUM Growth
+$2.6M
Cap. Flow
+$1.24M
Cap. Flow %
1%
Top 10 Hldgs %
69.52%
Holding
284
New
27
Increased
59
Reduced
25
Closed
10
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
201
Honeywell
HON
$71.4B
$4.63K ﹤0.01%
23
SCHW
202
Charles Schwab
SCHW
$177B
$4.39K ﹤0.01%
46
ROK icon
203
Rockwell Automation
ROK
$51.1B
$4.19K ﹤0.01%
12
IQV icon
204
IQVIA
IQV
$34.4B
$4.18K ﹤0.01%
22
TEVA icon
205
Teva Pharmaceuticals
TEVA
$37.3B
$4.16K ﹤0.01%
+206
New +$3.62K
CPB icon
206
Campbell Soup
CPB
$6.6B
$4.01K ﹤0.01%
127
+2
+2% +$65
ASML icon
207
ASML
ASML
$672B
$3.87K ﹤0.01%
+4
New +$3.14K
QUAL icon
208
iShares MSCI USA Quality Factor ETF
QUAL
$46B
$3.7K ﹤0.01%
19
NVO
209
Novo Nordisk
NVO
$223B
$3.5K ﹤0.01%
+63
New +$3.69K
CHTR icon
210
Charter Communications
CHTR
$16.4B
$3.3K ﹤0.01%
12
IWD icon
211
iShares Russell 1000 Value ETF
IWD
$81.9B
$3.26K ﹤0.01%
16
FIVE icon
212
Five Below
FIVE
$11.2B
$3.09K ﹤0.01%
20
VTRS icon
213
Viatris
VTRS
$20.1B
$3.01K ﹤0.01%
304
CRH icon
214
CRH
CRH
$68.7B
$2.88K ﹤0.01%
+24
New +$2.54K
CSCO icon
215
Cisco
CSCO
$442B
$2.87K ﹤0.01%
42
RTX icon
216
RTX Corp
RTX
$262B
$2.85K ﹤0.01%
17
EW icon
217
Edwards Lifesciences
EW
$49.5B
$2.8K ﹤0.01%
36
SNA icon
218
Snap-on
SNA
$21.2B
$2.77K ﹤0.01%
8
PRME icon
219
Prime Medicine
PRME
$569M
$2.77K ﹤0.01%
500
GIB icon
220
CGI
GIB
$14.2B
$2.76K ﹤0.01%
+31
New +$3K
CCEP icon
221
Coca-Cola Europacific Partners
CCEP
$46.4B
$2.71K ﹤0.01%
30
CLS icon
222
Celestica
CLS
$34.5B
$2.71K ﹤0.01%
+11
New +$2.22K
FIS icon
223
Fidelity National Information Services
FIS
$21.7B
$2.64K ﹤0.01%
40
ACA icon
224
Arcosa
ACA
$7.11B
$2.44K ﹤0.01%
26
GE icon
225
GE Aerospace
GE
$365B
$2.41K ﹤0.01%
8

Similar funds

Fairman Group's Q3 2025 Portfolio in Review

As of Q3 2025, Fairman Group held 284 positions worth $124M, up 2.1% from $122M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Fairman Group's Q3 2025 filing shows 27 new, 59 increased, 25 reduced and 10 closed positions. Its largest new stake was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M. The largest sale was Essent Group, an estimated $1.46M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Fairman Group's largest Q3 2025 buy was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M.
  • Fairman Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $2.18M increase.
  • Fairman Group's biggest Q3 2025 reduction was Essent Group, cutting an estimated $1.46M.
  • Fairman Group fully exited State Street SPDR Portfolio Developed World ex-US ETF in Q3 2025, selling an estimated $75.8K.
  • Fairman Group's ten largest holdings make up 70% of its $124M portfolio in Q3 2025.
  • Fairman Group opened 27 new positions and closed 10 in Q3 2025.
  • Fairman Group's portfolio value rose 2.1% quarter-over-quarter to $124M.

Based on Fairman Group's 13F filing for Q3 2025, filed 31 Oct 2025.